SCHEMBL10207129

SCHEMBL10207129

CC(=O)N1CC(=O)O[C@@H](c2ccccc2)[C@H]1c1ccccc1

nearest known ligand 0.49

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.49
ELANE P08246 1/20 0.42
TSHR P16473 3/20 0.41
KMT2A Q03164 2/20 0.41
MEN1 O00255 1/20 0.41
HTT P42858 1/20 0.41
CYP2C19 P33261 2/20 0.39
CYP3A4 P08684 1/20 0.39
ATM Q13315 1/20 0.38
GAA P10253 2/20 0.38
HHAT Q5VTY9 1/20 0.38
ALDH1A1 P00352 2/20 0.37
LMNA P02545 1/20 0.37
USP2 O75604 1/20 0.37
KIF11 P52732 1/20 0.37
CYP2C9 P11712 1/20 0.37
ABCB1 P08183 1/20 0.37
KDM4E B2RXH2 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7900809 0.88 GAA (0.40) POLBELANETSHRKMT2AMEN1
SCHEMBL3728141 0.88 GAA (0.40) POLBELANETSHRKMT2AMEN1
SCHEMBL6822684 0.88 GAA (0.40) POLBELANETSHRKMT2AMEN1
SCHEMBL9235945 0.88 GAA (0.40) POLBELANETSHRKMT2AMEN1
SCHEMBL3706217 0.81 NR1H2 (0.42) TSHRKMT2AMEN1USP2ABCB1
SCHEMBL894292 0.81 NR1H2 (0.42) TSHRKMT2AMEN1USP2ABCB1
SCHEMBL894291 0.81 NR1H2 (0.42) TSHRKMT2AMEN1USP2ABCB1
SCHEMBL14897525 0.78 RAB9A (0.40) POLBTSHRGAAALDH1A1
SCHEMBL13681382 0.78 ALDH1A1 (0.41) TSHRKMT2AMEN1CYP2C19ATM
SCHEMBL18100184 0.75 CYP2C9 (0.36) ELANETSHRKMT2AMEN1CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9994594-B2 Inhibitors of arginase and their therapeutic applications MARS, INCORPORATED (US) 2018-06-12 US disclosed
US-20170183362-A1 INHIBITORS OF ARGINASE AND THEIR THERAPEUTIC APPLICATIONS MARS, INCORPORATED 2017-06-29 US disclosed
US-9040703-B2 Inhibitors of arginase and their therapeutic applications MARS, INCORPORATED (US) 2015-05-26 US disclosed
US-20140371175-A1 INHIBITORS OF ARGINASE AND THEIR THERAPEUTIC APPLICATIONS MARS, INCORPORATED 2014-12-18 US disclosed
US-20140343019-A1 INHIBITORS OF ARGINASE AND THEIR THERAPEUTIC APPLICATIONS MARS, INCORPORATED 2014-11-20 US disclosed
US-20120083469-A1 INHIBITORS OF ARGINASE AND THEIR THERAPEUTIC APPLICATIONS MARS, INCORPORATED 2012-04-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140343019-A1 INHIBITORS OF ARGINASE AND THEIR THERAPEUTIC APPLICATIONS ARG1, ARG2, PRMT1 POLB 2146/4885ELANE 452/4885TSHR 1815/4885
US-20170183362-A1 INHIBITORS OF ARGINASE AND THEIR THERAPEUTIC APPLICATIONS ARG1, ARG2, PRMT9 POLB 2465/4885ELANE 1407/4885TSHR 634/4885
US-20120083469-A1 INHIBITORS OF ARGINASE AND THEIR THERAPEUTIC APPLICATIONS ARG1, ARG2, PRMT9 POLB 2465/4885ELANE 1407/4885TSHR 634/4885
US-20140371175-A1 INHIBITORS OF ARGINASE AND THEIR THERAPEUTIC APPLICATIONS ARG1, ARG2, PRMT9 POLB 2465/4885ELANE 1407/4885TSHR 634/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.